Grants
Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
Title |
Type![]() |
$ Amount | Activity | Investigator | Unit | Sponsor | Date |
---|---|---|---|---|---|---|---|
An Open-Label Single Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension | Contract | $146,463.72 | Clinical Trial | Franz Rischard | Medicine | Insmed Incorporated | 12/2021 |
Academic Detailing for HIV Prevention and Care | Contract | $15,000.00 | Instruction | Danielle Avila | Medicine | Arizona Department of Health Services | 05/2022 |
Phase 2, Prospective, Single Arm Medical Food Study to Evaluate a Standardized Nonessential Amino Acid Restriction (NEAAR) Medical Food for the Dietary Management of Metastatic Pancreatic Cancer | Contract | $227,886.12 | Clinical Trial | Rachna Shroff | Cancer Center Division | Faeth Therapeutics, Inc. | 03/2022 |
TransitionInAction Clinic | Contract | $49,297.00 | Other Sponsored Activity | Wendy Parent-Johnson | Family and Community Medicine | Arizona Developmental Disabilities Planning Council | 01/2020 |
The National Nursing Home COVID Action Network | Contract | $400,000.00 | Other Sponsored Activity | Mindy Fain | Arizona Center on Aging | University of New Mexico | 12/2020 |
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contacts | Contract | $207,346.24 | Clinical Trial | Sairam Parthasarathy | Medicine | Regeneron Pharmaceuticals, Inc | 09/2020 |
TruGraf Long-term Clinical Outcomes Study | Contract | Clinical Trial | VENKATESH KUMAR ARIYAMUTHU | Medicine | Transplant Genomics, Inc. | 03/2021 | |
A Three-arm, Parallel Group, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of AB-2004 in a 13 to 17 year-old Autism Spectrum Disorder Population | Contract | $189,110.48 | Clinical Trial | Sydney Rice | Pediatrics | Axial Therapeutics, Inc. | 01/2022 |
A Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-Resistant Prostate Cancer | Contract | $227,327.00 | Clinical Trial | Alejandro Recio Boiles | Cancer Center Division | Syneos Health | 04/2021 |
A New Network of Household Transmission Studies for Vaccine Effectiveness | Contract | $626,825.00 | Research | Katherine Ellingson | Epidemiology and Biostatistics | Vanderbilt University Medical Center | 10/2021 |
iCLAS for Persistent Atrial Fibrillation | Contract | $193,319.94 | Clinical Trial | Wilber Su | COM Phx Internal Medicine | Adagio Medical, Inc | 02/2021 |
An Open-Label, Phase 2 Trial of Nanatinostat in Combination with Valganciclovir in Subjects with Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas (NAVAL-1) | Contract | $323,960.68 | Clinical Trial | Abhijeet Kumar | Cancer Center Division | Pharmaceutical Research Associates | 04/2022 |
Multicenter, Open Label Trial To Investigate the Efficacy and Safety of a Single Oral Dose of 1.0 mg Kg Macimorelin Acetate As Growth Hormone Stimulation Test (GHST) in Pediatric Patients With..... | Contract | $160,244.72 | Clinical Trial | Mark Wheeler | Pediatrics | Aeterna Zentaris GmbH | 12/2021 |
Training Program in Health Outcomes and Pharmacoeconomic Research | Contract | $36,540.00 | Research training | Jason Hurwitz | HOPE Center | Veloxis Pharmaceuticals Inc. | 02/2020 |
Development of a Patient-reported Comprehensive Medication Review Experience Questionnaire | Contract | $140,420.00 | Research | Terri Warholak | Pharmacy Practice and Science | Pharmacy Quality Alliance | 06/2021 |
Third Renewal of the Intergovernmental Agreement between The City of Tucson and The Arizona Board of Regents | Contract | $88,000.00 | Research | Kelly Reynolds | Community Environment & Policy | City of Tucson, Arizona | 07/2020 |
Prospective Clinical and Imaging Outcomes of Acute Pulmonary Embolism Following Catheter Directed Aspiration Thrombectomy Versus Conservative Therapy Alone: a Pilot Study | Contract | $153,562.52 | Clinical Trial | Gregory Woodhead | Medical Imaging | Inari Medical | 03/2022 |
Evaluation of Drug Efficacy in a Rat Model of Neuropathic Pain | Contract | $275,676.00 | Research | Rajesh Khanna | Pharmacology | Lovelace Biomedical and Environmental Research Institute | 01/2020 |
Collaborative Islet Transplant Registry (CITR) | Contract | $20,000.00 | Clinical Trial | Robert Harland | Surgery | The EMMES Corporation, LLC | 07/2020 |
A Novel Polymeric Valve for Transcatheter Aortic Valve Replacement | Contract | $532,239.00 | Research | Marvin Slepian | UAHS Research | PolyNova Cardiovascular, LLC | 12/2020 |
A Phase I/II Pilot Trial, Single Arm, Open Label, of Protein-bound Paclitaxel, Cisplatin, And Gemcitabine (GCN) Combined with Tumor Treatment Fields (TTF) in Patient with Metastatic Pancreatic... | Contract | $161,422.69 | Clinical Trial | Hani Babiker | Cancer Center Division | NovoCure | 09/2020 |
SAVAHCS: IPA for Yuguo Wang (Wertheim) | Contract | $20,483.71 | Research | Jason Wertheim | Surgery | United States Department of Veterans Affairs | 04/2021 |
An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH | Contract | $447,126.32 | Clinical Trial | Franz Rischard | Medicine | Acceleron Pharmaceuticals | 01/2022 |
A Phase 3, Open-label, Single Arm, Multicenter Study of Ravulizumab in Addition to Best Supportive Care in Pediatric Participants (From 1 Month to < 18 Years of Age) with Thrombotic Microangiopathy (T | Contract | $128,697.00 | Clinical Trial | Emmanuel Katsanis | Cancer Center Division | IQVIA RDS Inc. | 04/2021 |
Validation of Targeting the FAK FAT Domain in Cancer | Contract | $226,162.00 | Research | Timothy Marlowe | COM Phx Internal Medicine | Leidos Biomedical Research Incorporated | 07/2021 |